The scientist’s investigation covers issues in Immunology, Virology, Acquired immunodeficiency syndrome, Viral load and Developing country. As a part of the same scientific family, John N. Nkengasong mostly works in the field of Immunology, focusing on Quality assurance and, on occasion, MEDLINE, Medical physics, Referral and Test. John N. Nkengasong is involved in the study of Virology that focuses on Virus in particular.
His work deals with themes such as Clinical trial, Program evaluation, Family medicine, Creatinine and Pediatrics, which intersect with Acquired immunodeficiency syndrome. The concepts of his Viral load study are interwoven with issues in Resistance mutation and Antiretroviral therapy. His Developing country research is multidisciplinary, incorporating perspectives in Accreditation, Tuberculosis, Engineering management and Environmental health.
John N. Nkengasong focuses on Virology, Viral load, Immunology, Acquired immunodeficiency syndrome and Virus. His Virology research incorporates elements of Antibody, Drug resistance and Genotype. John N. Nkengasong has researched Viral load in several fields, including RNA, Confidence interval, Zidovudine and Antiretroviral therapy.
His research ties Internal medicine and Immunology together. His Acquired immunodeficiency syndrome study combines topics in areas such as Developing country, Serology, Tuberculosis and Public health. His Virus research incorporates themes from Genetic variability, Recombinant DNA, Polymerase chain reaction and Phylogenetic tree.
His main research concerns Coronavirus disease 2019, 2019-20 coronavirus outbreak, Severe acute respiratory syndrome coronavirus 2, Economic growth and Pandemic. His 2019-20 coronavirus outbreak study improves the overall literature in Virology. His Virology research includes themes of Seroepidemiologic Studies and Genomics.
His Economic growth research is multidisciplinary, relying on both Disease and Public health. His Pandemic research incorporates elements of Case fatality rate and Serology. His study looks at the relationship between Medical emergency and fields such as Diagnostic accuracy, as well as how they intersect with chemical problems.
John N. Nkengasong mainly focuses on Coronavirus disease 2019, Economic growth, Pandemic, Public health and 2019-20 coronavirus outbreak. His Coronavirus disease 2019 research is multidisciplinary, incorporating elements of Developing country, MEDLINE and Pneumonia. John N. Nkengasong has included themes like Test, Serology and Scale in his Pandemic study.
His studies deal with areas such as Triage and Vaccination as well as Public health. In his study, Virology, Seroepidemiologic Studies and Medical emergency is strongly linked to Severe acute respiratory syndrome coronavirus 2, which falls under the umbrella field of 2019-20 coronavirus outbreak. His Global health study combines topics from a wide range of disciplines, such as Accreditation, Acquired immunodeficiency syndrome, Health policy and Quality management.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial
Stefan Z Wiktor;Ehounou Ekpini;John M Karon;John Nkengasong.
The Lancet (1999)
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
Linda M. Parsons;Ákos Somoskövi;Cristina Gutierrez;Evan Lee.
Clinical Microbiology Reviews (2011)
Looming threat of COVID-19 infection in Africa: act collectively, and fast
John N Nkengasong;Wessam Mankoula.
The Lancet (2020)
The puzzle of HIV-1 subtypes in Africa
Wouter Janssens;Anne Buvé;John N. Nkengasong.
Serology testing in the COVID-19 pandemic response.
Rosanna W Peeling;Catherine J Wedderburn;Catherine J Wedderburn;Patricia J Garcia;Debrah Boeras.
Lancet Infectious Diseases (2020)
Genetic diversity of HIV in Africa: impact on diagnosis treatment vaccine development and trials.
Martine Peeters;Coumba Toure-Kane;John N Nkengasong.
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
Yen T. Duong;Maofeng Qiu;Anindya K. De;Keisha Jackson.
PLOS ONE (2012)
Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.
Wim Jennes;Sonja Verheyden;Christian Demanet;Christiane A. Adjé-Touré.
Journal of Immunology (2006)
The World Health Organization African Region Laboratory Accreditation Process Improving the Quality of Laboratory Systems in the African Region
Guy-Michel Gershy-Damet;Philip Rotz;David Cross;El Hadj Belabbes.
American Journal of Clinical Pathology (2010)
Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group.
Danuta Pieniazek;Mark Rayfield;Dale J. Hu;John Nkengasong.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: